Witsch, Jens http://orcid.org/0000-0001-8924-851X
Siegerink, Bob
Nolte, Christian H.
Sprügel, Maximilian
Steiner, Thorsten
Endres, Matthias
Huttner, Hagen B.
Article History
Received: 3 March 2021
Accepted: 19 March 2021
First Online: 3 May 2021
Declarations
:
: The UKER ICH-cohort study was approved by the ethics committees and institutional review boards based on the central vote from Friedrich-Alexander-University Erlangen-Nuremberg, Germany.
: Not applicable.
: Dr. Witsch is an editorial team member of the Resident & Fellow section of Neurology. Dr. Siegerink reports no disclosures. Dr. Nolte received research grants from German Ministry of Research and Education, German Center for Neurodegenerative Diseases, German Center for cardiovascular Research, and speaker and/or consultation fees from Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer Pharma, Portola and Abbott. Dr. Sprügel reports no disclosures. Dr. Steiner reports no disclosures. Dr. Endres reports grant support from Bayer, the German Research Foundation (DFG), the German Federal Ministry of Education and Research (BMBF), the German Center for Neurodegenerative Diseases (DZNE), the German Center for Cardiovascular Research (DZHK), the European Union, Corona Foundation, and Fondation Leducq; and fees paid to the Charité from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, Daiichi Sankyo, Amgen, GlaxoSmithKline, Sanofi, Covidien, Novartis, all outside the submitted work. Dr. Huttner reports no disclosures.